V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10452359 | 10034309 | null | 74.3 | Curative (C) | 2017-01-14 | 2017-01-20 | Rituximab | 02 | N | RITUXIMAB | 100570705 |
| 10452361 | 10034310 | 1.49 | 71.8 | Curative (C) | 2017-08-24 | 2017-08-24 | Capecitabine | 2 | N | CAPECITABINE | 101127648 |
| 10452369 | 10034311 | 1.74 | 56.6 | Palliative (P) | 2019-10-02 | 2019-10-03 | Rituximab | N | N | RITUXIMAB | 100950730 |
| 10452371 | 10034312 | 1.7 | 60.2 | Curative (C) | 2020-02-12 | 2020-02-25 | Rituximab | 02 | N | RITUXIMAB | 100527638 |
| 10452415 | 10034313 | 1.75 | 64.1 | null | 2021-08-01 | 2021-08-03 | CAPECITABINE + RT | null | null | CAPECITABINE | 101411193 |
| 10452420 | 10034314 | 1.79 | 93 | null | 2021-10-15 | 2021-10-15 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101467745 |
| 10452436 | 10034315 | 1.61 | 82.6 | null | 2021-09-11 | 2021-10-05 | Capecitabine + Oxaliplatin 21day | 02 | null | IBRUTINIB | 100492728 |
| 10452441 | 10034316 | 1.72 | 145 | Adjuvant (A) | 2016-08-16 | 2016-09-11 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100403210 |
| 10452450 | 10034317 | 1.49 | 78 | 03 | 2017-11-27 | 2018-02-23 | Docetaxel | 02 | N | DOCETAXEL | 100984137 |
| 10452470 | 10034318 | 1.78 | 91 | 03 | 2020-08-31 | 2020-09-15 | CHOP R | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101180629 |
| 10452508 | 10034319 | 1.72 | 82.5 | Adjuvant (A) | 2021-08-04 | 2021-08-25 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101816273 |
| 10452515 | 10034320 | 1.66 | 60.3 | Palliative (P) | 2019-11-22 | 2019-11-22 | IBRUTINIB | 2 | N | IBRUTINIB | 101638750 |
| 10452526 | 10034321 | 1.89 | 82.4 | Palliative (P) | 2018-03-08 | 2018-03-26 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100154369 |
| 10452528 | 10034322 | 1.84 | 77.4 | null | 2022-01-10 | 2022-01-18 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101079446 |
| 10452557 | 10034323 | 1.84 | 92.3 | Palliative (P) | 2020-01-25 | 2020-01-28 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 101422800 |
| 10452563 | 10034324 | 1.6 | 54.6 | null | 2020-04-15 | 2020-05-21 | Capecitabine + Oxaliplatin 21day | 02 | null | IBRUTINIB | 100340418 |
| 10452589 | 10034325 | 1.65 | 68.4 | Curative (C) | 2013-11-02 | 2018-07-21 | IBRUTINIB | 02 | N | IBRUTINIB | 101672985 |
| 10452598 | 10034326 | 1.87 | 103.6 | Neo-adjuvant (N) | 2020-05-29 | 2020-07-03 | IBRUTINIB | 02 | null | IBRUTINIB | 101369236 |
| 10452604 | 10034327 | 1.58 | 62 | Curative (C) | 2019-07-21 | 2019-07-23 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 101232982 |
| 10452639 | 10034328 | 1.62 | 58 | 03 | 2019-01-16 | 2019-01-17 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 101864818 |
| 10452651 | 10034329 | 1.7 | 57.5 | Curative (C) | 2019-10-15 | 2019-11-03 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101122734 |
| 10452654 | 10034330 | 1.67 | 90.4 | Curative (C) | 2019-02-16 | 2019-02-25 | Rituximab | 02 | null | RITUXIMAB | 101855819 |
| 10452658 | 10034331 | 1.74 | 79 | Palliative (P) | null | 2018-10-24 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100754762 |
| 10452659 | 10034332 | 0 | 70 | null | 2021-04-21 | 2021-05-11 | Capecitabine + Oxaliplatin 21day | 02 | null | PEMBROLIZUMAB | 100829172 |
| 10452663 | 10034333 | 0 | 54 | Palliative (P) | 2019-09-19 | 2019-10-25 | Rituximab | 02 | N | RITUXIMAB | 100344093 |
| 10452686 | 10034334 | 1.88 | 65.3 | null | null | 2015-08-27 | Rituximab | 02 | null | RITUXIMAB | 101553648 |
| 10452687 | 10034335 | 1.76 | 85 | null | 2019-06-20 | 2019-06-25 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101428121 |
| 10452688 | 10034336 | 1.76 | 84 | Palliative (P) | 2019-07-29 | 2019-08-24 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101148362 |
| 10452689 | 10034337 | 1.72 | 83.5 | Adjuvant (A) | 2018-06-06 | 2018-06-06 | Rituximab | 02 | N | RITUXIMAB | 101822160 |
| 10452724 | 10034338 | 1.65 | 79.1 | Palliative (P) | 2018-01-15 | 2018-01-29 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 100612131 |
| 10452741 | 10034339 | 1.55 | 74.4 | null | 2017-06-21 | 2017-06-21 | Rituximab | 02 | null | RITUXIMAB | 101560330 |
| 10452791 | 10034340 | 1.68 | 86.8 | Curative (C) | 2018-06-18 | 2018-06-26 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100110190 |
| 10452795 | 10034341 | 1.71 | 61.9 | Curative (C) | 2017-07-21 | 2017-07-21 | Docetaxel | 02 | N | DOCETAXEL | 100845475 |
| 10452805 | 10034342 | 1.77 | null | Neo-adjuvant (N) | 2019-03-31 | 2019-04-16 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100029927 |
| 10452809 | 10034343 | 1.7 | 61.75 | null | 2019-12-21 | 2020-01-11 | Docetaxel | 02 | null | DOCETAXEL | 101101526 |
| 10452833 | 10034344 | 1.72 | 85.5 | Palliative (P) | 2019-07-24 | 2019-08-18 | Capecitabine + Oxaliplatin 21day | N | N | DOCETAXEL | 101866913 |
| 10452839 | 10034345 | 1.51 | 101.8 | null | 2018-12-18 | 2019-01-05 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101062851 |
| 10452846 | 10034346 | 1.69 | 113.3 | Adjuvant (A) | 2016-02-19 | 2016-03-04 | Capecitabine | 02 | N | CAPECITABINE | 101655360 |
| 10452847 | 10034347 | 1.84 | 85.7 | Curative (C) | 2019-12-25 | 2019-12-25 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101387982 |
| 10452867 | 10034348 | 1.64 | 81 | null | 2019-05-21 | 2019-06-11 | Docetaxel | 02 | null | DOCETAXEL | 101843091 |
| 10452868 | 10034349 | null | null | 03 | 2017-04-01 | 2017-04-01 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100144562 |
| 10452893 | 10034350 | 1.6 | 56 | null | 2018-11-10 | 2018-11-24 | Capecitabine | 02 | null | CAPECITABINE | 101046635 |
| 10452917 | 10034351 | 1.89 | 86 | Neo-adjuvant (N) | 2019-01-17 | 2019-01-19 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 100562469 |
| 10452922 | 10034352 | 1.66 | 121 | Adjuvant (A) | 2019-02-14 | 2019-03-03 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 101028244 |
| 10452977 | 10034353 | 1.68 | 69 | null | 2022-02-20 | 2022-03-06 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 100982804 |
| 10452991 | 10034354 | 1.66 | 75.7 | Palliative (P) | 2019-01-14 | 2019-01-18 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101841219 |
| 10452999 | 10034355 | 1.51 | 58.9 | Curative (C) | 2018-10-16 | 2018-11-06 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 101654210 |
| 10453005 | 10034356 | 1.68 | 76.4 | null | 2016-09-14 | 2016-09-15 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101368080 |
| 10453006 | 10034357 | 1.79 | 104.6 | Palliative (P) | 2017-06-17 | 2017-06-24 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101760132 |
| 10453019 | 10034358 | 1.74 | 95 | Palliative (P) | 2015-10-05 | 2015-10-06 | Rituximab | 02 | N | RITUXIMAB | 100035453 |